No impairment of peripheral deposition in novel asthmatics treated with an MDI corticosteroid with spacer.

@article{Saari2003NoIO,
  title={No impairment of peripheral deposition in novel asthmatics treated with an MDI corticosteroid with spacer.},
  author={Stacy M. Saari and Mika Vidgren and V{\"a}in{\"o} M h Turjanmaa and Matti O. Koskinen and Markku M. Nieminen},
  journal={Respiratory medicine},
  year={2003},
  volume={97 2},
  pages={
          152-8
        }
}
Pulmonary distribution and lung functions were evaluated during a 4-month inhaled corticosteroid treatment period in 10 steroid-naïve novel asthmatics with normal or slightly reduced lung functions. Patients were given a total daily dose of 1000 microg of beclomethasone dipropionate aerosol twice a day via a pressured metered dose inhaler with a large-volume chamber device (Volumatic, GlaxoSmith Kline, U.K.). Gamma lung scintigraphy and lung function tests were performed before and after 2… CONTINUE READING
3 Citations
38 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 38 references

Prevention of asthma exacerbations by HFA flunisolide in adults and adolescents with mild-to-moderate asthma

  • H Nelson, K. Newman
  • J Allergy Clin Immunol
  • 2001
1 Excerpt

The relevance of site of airway inflammation in asthma and targeted aerosol delivery

  • PH Howarth
  • Int J Clin Pract
  • 1999
1 Excerpt

Similar Papers

Loading similar papers…